日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Haemophilus influenzae Mu-like prophage FluMu DNA-binding protein Ner (nlp) CSB-YP341623HTA
CSB-EP341623HTA
CSB-BP341623HTA
CSB-MP341623HTA
CSB-EP341623HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helianthus annuus 11 kDa late embryogenesis abundant protein CSB-YP341624HUO
CSB-EP341624HUO
CSB-BP341624HUO
CSB-MP341624HUO
CSB-EP341624HUO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brassica napus ATP-dependent Clp protease ATP-binding subunit clpA homolog, chloroplastic (CLPA), partial CSB-YP341625BWD
CSB-EP341625BWD
CSB-BP341625BWD
CSB-MP341625BWD
CSB-EP341625BWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hordeum vulgare Late embryogenesis abundant protein B19.1B (B19.1B) CSB-YP341626HWQ
CSB-EP341626HWQ
CSB-BP341626HWQ
CSB-MP341626HWQ
CSB-EP341626HWQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable leucine carboxyl methyltransferase 1 (B0285.4) CSB-YP341627CXY
CSB-EP341627CXY
CSB-BP341627CXY
CSB-MP341627CXY
CSB-EP341627CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serpentine receptor class gamma-1 (srg-1), partial CSB-YP341628CXY1
CSB-EP341628CXY1
CSB-BP341628CXY1
CSB-MP341628CXY1
CSB-EP341628CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tryptophan--tRNA ligase, mitochondrial (wars-2), partial CSB-YP341629CXY
CSB-EP341629CXY
CSB-BP341629CXY
CSB-MP341629CXY
CSB-EP341629CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Homeobox-leucine zipper protein GLABRA 2 (GL2), partial CSB-YP341630DOA
CSB-EP341630DOA
CSB-BP341630DOA
CSB-MP341630DOA
CSB-EP341630DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zea mays Apocytochrome f (petA), partial CSB-YP341631ZAX1
CSB-EP341631ZAX1
CSB-BP341631ZAX1
CSB-MP341631ZAX1
CSB-EP341631ZAX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zea mays Photosystem I assembly protein Ycf4 (ycf4), partial CSB-YP341632ZAX1
CSB-EP341632ZAX1
CSB-BP341632ZAX1
CSB-MP341632ZAX1
CSB-EP341632ZAX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Nuclear mRNA export protein SAC3 (SAC3), partial CSB-YP341633SVG
CSB-EP341633SVG
CSB-BP341633SVG
CSB-MP341633SVG
CSB-EP341633SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Gibberellin-regulated protein 2 (GASA2) CSB-YP341634DOA
CSB-EP341634DOA
CSB-BP341634DOA
CSB-MP341634DOA
CSB-EP341634DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Histidine--tRNA ligase (hisS) CSB-YP341635MVN
CSB-EP341635MVN
CSB-BP341635MVN
CSB-MP341635MVN
CSB-EP341635MVN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glutamate-1-semialdehyde 2,1-aminomutase (hemL) CSB-YP341636MVN
CSB-EP341636MVN
CSB-BP341636MVN
CSB-MP341636MVN
CSB-EP341636MVN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ribosomal protein S7, mitochondrial (RPS7) CSB-YP341638EZF
CSB-EP341638EZF
CSB-BP341638EZF
CSB-MP341638EZF
CSB-EP341638EZF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ribosomal protein S14, mitochondrial (RPS14) CSB-YP341639EZF
CSB-EP341639EZF
CSB-BP341639EZF
CSB-MP341639EZF
CSB-EP341639EZF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba castellanii Ribosomal protein S12, mitochondrial (RPS12) CSB-YP341640AAJ
CSB-EP341640AAJ
CSB-BP341640AAJ
CSB-MP341640AAJ
CSB-EP341640AAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba castellanii 60S ribosomal protein L11, mitochondrial (RPL11) CSB-YP341641AAJ
CSB-EP341641AAJ
CSB-BP341641AAJ
CSB-MP341641AAJ
CSB-EP341641AAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae 30S ribosomal protein S4 (rpsD) CSB-YP341642MLW
CSB-EP341642MLW
CSB-BP341642MLW
CSB-MP341642MLW
CSB-EP341642MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Catalase-peroxidase (katG), partial CSB-YP341643MVH
CSB-EP341643MVH
CSB-BP341643MVH
CSB-MP341643MVH
CSB-EP341643MVH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×